Latest Comments on ChinaBio Today's Articles

1. Tom B on China Biotech Week in Review: Two More R&D Centers, One PE Fund, One IPO: And, risking the health of Americans with shady overseas safety... more »
2. a. palmer jr. on China Biotech Week in Review: Two More R&D Centers, One PE Fund, One IPO: In short, Pfizer is closing plants in the United States and... more »
3. balabanovj on China Sky One Nears Approval on Two Diagnostic Tests : This is truly a great company with great vision that has been... more »
4. a. palmer jr. on Pfizer Increases R&D Commitment in China: It's just a matter of time before China gets greedy like we did... more »
5. biomedlives on Pfizer Increases R&D Commitment in China: This story isn't very encouraging for Americans thinking of going... more »
6. a. palmer jr. on Pfizer Increases R&D Commitment in China: I guess now we'll have to worry about lead in our medicine! more »
7. fran grady on Sinovac Adds Vaccine Capacity by Forming JV: Sinovac has prospered in the second half of the year with its... more »
8. BlueOkie on Pfizer Increases R&D Commitment in China: Makes sense! PFE sells more outside the US than in. Of Approx... more »
9. P1llman on Merck Serono to Spend $225 Million on New Beijing R&D Center: The stock ticker MRK is used incorrectly in this story. MRK is... more »
10. huangthomas on Tongjitang Chinese Medicines Reports Another Bad Quarter : This is the time for investors to pause and examine how nascent... more »
11. Jason Tillberg on American Oriental's Q3 Disappoints Again : You can make the case that when stocks go from being good values... more »
12. User 49089 on Sinovac’s Q3 Soars: boy I would hate to see the stock if they had bad news ! more »
13. Mayascribe on Sinovac’s Q3 Soars: Fran Grady: Only booked 586,000 doses with nearly another 11... more »
14. fran grady on Sinovac’s Q3 Soars: Sales "soar" so why stock goes down??? What are you not telling us? more »
15. User 282993 on Sinovac Set to Move Listing to NASDAQ: This stock has proven it's a winner in more ways than one. As soon... more »